Equities

Transmedics Group Inc

Transmedics Group Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)85.98
  • Today's Change0.48 / 0.56%
  • Shares traded1.25m
  • 1 Year change+40.47%
  • Beta2.0570
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

  • Revenue in USD (TTM)401.09m
  • Net income in USD32.64m
  • Incorporated2018
  • Employees584.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Premier Inc1.28bn147.17m2.20bn2.90k16.561.158.381.721.381.3711.6519.980.3562--2.99439,914.103.837.084.788.9567.2461.2910.7616.05----0.277127.320.76842.03-31.70-11.93-2.76--
Conmed Corp1.29bn131.74m2.27bn4.00k17.372.4311.141.764.234.2341.3830.210.5551.715.58322,029.005.680.89726.621.0255.6554.9510.231.651.065.220.5021139.1619.067.68179.9910.042.890.00
Omnicell Inc1.06bn-17.69m2.31bn3.65k--1.8734.762.17-0.3917-0.391723.1726.770.47045.914.06291,563.30-0.78171.73-1.112.2541.3846.69-1.662.920.9529--0.31720.00-11.487.82-460.68--0.235--
Warby Parker Inc742.53m-32.56m2.34bn2.14k--6.97206.123.15-0.2731-0.27316.202.801.225.70818.21346,975.20-5.37---6.78--55.3257.49-4.39-14.532.06--0.00--11.9819.6742.75------
LeMaitre Vascular Inc213.03m41.32m2.34bn614.0057.187.0845.9711.001.821.829.4114.730.59921.117.59346,952.8011.629.0212.669.9368.3465.8319.4015.455.52----40.4119.6912.8845.895.9618.9315.51
Enovis Corp2.00bn-121.38m2.59bn6.55k--0.778717.731.30-2.21-2.1736.4359.610.40231.595.91305,598.20-2.43-0.3569-2.66-0.4156.9648.19-6.03-1.061.120.98890.2876--9.22-4.89-40.29--11.91--
UFP Technologies Inc461.85m54.21m2.65bn3.09k49.288.0439.365.737.007.0059.6442.890.88964.186.15149,320.4010.449.6912.0010.9528.3126.3311.7410.141.4313.440.39180.0013.0816.007.5025.7114.08--
Irhythm Technologies Inc560.03m-150.66m2.71bn2.00k--37.70--4.83-4.85-4.8518.042.290.8312.568.79280,012.50-22.33-21.92-26.27-26.7767.8369.39-26.90-25.756.12-24.180.90--19.9027.32-6.24--50.82--
LivaNova PLC1.24bn23.68m2.80bn2.90k121.222.1441.312.260.42590.425922.8124.130.51192.476.42428,185.900.9777-6.011.12-7.4267.7866.991.91-13.562.872.460.3234--12.890.8278120.34---1.64--
TransMedics Group Inc401.09m32.64m2.89bn584.0091.5813.7557.217.190.93890.938911.606.250.54393.565.32686,797.904.43-16.084.78-17.9559.3465.378.14-40.477.33--0.7078--158.5379.3630.92--225.12--
Quidelortho Corp2.83bn-1.86bn2.94bn7.10k--0.925--1.04-27.79-27.7942.3547.300.3722.589.15399,239.40-24.4011.34-27.5112.9147.8962.71-65.6020.930.79290.78950.44690.00-8.2141.83-101.84--45.87--
Inari Medical Inc574.50m-78.58m3.01bn1.30k--6.91--5.24-1.35-1.359.907.440.92211.597.46441,921.50-12.61-0.5941-15.24-0.669686.8289.06-13.68-0.62951.40--0.00--28.73135.4094.41--52.46--
Envista Holdings Corp2.50bn-1.34bn3.51bn12.80k--1.14--1.40-7.77-7.7714.5117.860.41064.216.19195,570.30-21.931.94-25.272.3454.2057.65-53.425.291.773.130.31630.00-0.1012-2.04-142.10---4.22--
Neogen Corp912.20m-23.53m3.52bn2.92k--1.1237.323.86-0.1086-0.10864.2114.470.20132.715.98312,718.20-0.51931.38-0.53461.4449.5648.23-2.584.312.791.030.22150.0012.3717.4158.81--50.02--
Guardant Health Inc692.26m-512.41m3.53bn1.78k------5.11-4.24-4.245.70-0.4880.4153.687.81389,126.50-30.72-22.26-35.19-24.5960.3164.62-74.02-97.075.85-8.041.06--25.4544.1426.76--0.2786--
Axonics Inc431.90m-5.66m3.60bn797.00--5.42527.598.33-0.108-0.1088.5213.000.6021.077.74541,909.70-0.7889-12.67-0.848-13.7676.5970.04-1.31-29.686.40--0.00--33.86249.0689.80--23.65--
Data as of Nov 08 2024. Currency figures normalised to Transmedics Group Inc's reporting currency: US Dollar USD

Institutional shareholders

49.11%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Jun 20244.07m12.20%
The Vanguard Group, Inc.as of 30 Jun 20242.43m7.28%
BlackRock Fund Advisorsas of 30 Jun 20242.34m7.03%
Driehaus Capital Management LLCas of 30 Jun 20241.49m4.46%
Invesco Advisers, Inc.as of 30 Jun 20241.27m3.81%
Eventide Asset Management LLCas of 30 Jun 20241.15m3.43%
ArrowMark Colorado Holdings LLCas of 30 Jun 20241.14m3.41%
Macquarie Investment Management Business Trustas of 30 Jun 2024956.30k2.87%
SSgA Funds Management, Inc.as of 30 Jun 2024782.79k2.35%
Geode Capital Management LLCas of 30 Jun 2024753.68k2.26%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.